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Abstract
Background.Major depressive disorder and neuroticism (Neu) share a large genetic basis. We
sought to determine whether this shared basis could be decomposed to identify genetic factors
that are specific to depression.
Methods. We analysed summary statistics from genome-wide association studies (GWAS) of
depression (from the Psychiatric Genomics Consortium, 23andMe and UK Biobank) and
compared them with GWAS of Neu (from UK Biobank). First, we used a pairwise GWAS ana-
lysis to classify variants as associated with only depression, with only Neu or with both.
Second, we estimated partial genetic correlations to test whether the depression’s genetic
link with other phenotypes was explained by shared overlap with Neu.
Results.We found evidence that most genomic regions (25/37) associated with depression are
likely to be shared with Neu. The overlapping common genetic variance of depression and
Neu was genetically correlated primarily with psychiatric disorders. We found that the genetic
contributions to depression, that were not shared with Neu, were positively correlated with
metabolic phenotypes and cardiovascular disease, and negatively correlated with the person-
ality trait conscientiousness. After removing shared genetic overlap with Neu, depression still
had a specific association with schizophrenia, bipolar disorder, coronary artery disease and
age of first birth. Independent of depression, Neu had specific genetic correlates in ulcerative
colitis, pubertal growth, anorexia and education.
Conclusion. Our findings demonstrate that, while genetic risk factors for depression are
largely shared with Neu, there are also non-Neu-related features of depression that may be
useful for further patient or phenotypic stratification.
Introduction
Major depressive disorder (MDD) is a leading cause of morbidity worldwide, currently affect-
ing approximately 4% of the world’s population (World Health Organization, 2017). MDD is
classified by the World Health Organisation and American Psychiatric Association according
to its severity, its recurrence or chronicity, and the presence or absence of psychotic symptoms.
This approach aims to maximise the reliability of MDD’s diagnosis while being agnostic about
its underlying aetiology until robust evidence of causal mechanisms can be used to stratify the
condition.
Historically, depression had been classified on the basis of pre-existing emotional instability
into ‘neurotic’ and ‘endogenous’ forms (Kendell, 1977). ‘Neurotic depression’ was diagnosed in
the presence of pre-existing emotional instability and was reported to occur in younger indi-
viduals who more frequently expressed suicidal ideation. ‘Endogenous depression’, in contrast,
was characterised by more frequent melancholic symptoms, including disrupted sleep,
impaired appetite, diurnal variation of mood and impaired cognition. Individuals with
endogenous depression were described as more responsive to antidepressant treatments
(Fava et al., 2008).
The nosological status of neurotic and endogenous depression has, however, been very con-
troversial (Parker, 2000). Some studies have found empirical support for the neurotic/
endogenous division based upon self-report and clinical data (Zimmerman et al., 1986),
whereas other studies found little empirical support for the distinction and noted that
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individuals with low mood responded to antidepressant treat-
ments regardless of their subtype (Arnow et al., 2015).
The tendency towards emotional instability, or neuroticism
(Neu), is a robustly and consistently replicated dimension of per-
sonality that is relatively stable over time (Eysenck, 1947). Neu
features in the most widely accepted theory of personality
structure, the Five Factor model, alongside openness to experi-
ence, extraversion, conscientiousness and agreeableness
(Digman, 1990). Trait Neu (sometimes also labelled as
emotionality or its opposite, emotional stability) is identified con-
sistently and is composed of items reflecting low mood, stress sen-
sitivity, irritability and emotional control (McCrae and Costa,
1987).
Twin, family and genomic studies have shown that population
variation in Neu and liability to depression are conferred by both
genetic and environmental risk factors (Sullivan et al., 2000;
Keller et al., 2005; Lubke et al., 2012; Boraska et al., 2014; Zeng
et al., 2016; Hill et al., 2018). While earlier studies (Major
Depressive Disorder Working Group of the Psychiatric GWAS
Consortium, 2013) had difficulty in discovering specific genetic
variants for depression, possibly partly because of heterogeneity
(Levinson et al., 2014), recent studies have identified genome-
wide significantly associated loci either by focusing on more
rigorously defined MDD phenotypes (CONVERGE Consortium,
2015) or by meta-analysing case–control samples with larger
sample-size studies that use broader major depression (MD) phe-
notypes (Hyde et al., 2016; Direk et al., 2017; Howard et al., 2018,
2019; Wray et al., 2018; Amare et al., 2019). Results from genome-
wide association studies (GWAS) of MD primarily implicate
brain-expressed genes, developmental regulatory pathways and
education and body mass index (BMI) as causal factors. Recent
studies of Neu have also identified over 100 genome-wide signifi-
cant loci (Luciano et al., 2017; Nagel et al., 2018), and likewise are
associated with genes involved in neuronal genesis. More recent
work examining the heterogeneity of Neu has identified many
more loci that are specific to the traits that make-up Neu.
Confirming earlier findings from biometric studies (Fanous
et al., 2002; Kendler et al., 2006), these studies have shown that
depression and Neu have a genetic correlation of between 0.45
and 0.7 and thus share a moderate to substantial proportion of
their genetic architecture (Luciano et al., 2017). Since this genetic
correlation is sizeable but still less than 1, it suggests that depres-
sion and Neu are either both unreliable measures of the same
underlying genetic predisposition or it indicates that depression
and Neu may not be identical in terms of their genetic architec-
ture. This may be because the effect sizes of each variant
(Chesmore et al., 2018) differ between depression and Neu,
which includes the possibility that some variants affect one trait
but not the other. A third (non-exclusive) possibility is that
Neu or one of its facets is directly related to only a subtype of
depression and that other subtypes will have distinct genetic aeti-
ologies (Kendler et al., 2013; Hill et al., 2019).
In the current study we sought to compare genome-wide asso-
ciation summary statistics for depression and Neu to test whether
there are specific genetic contributions to depression that are
independent of Neu. First, we sought to identify loci that con-
ferred a higher risk of depression, but not higher Neu, and vice
versa. We then annotated the function of any associated loci.
Second, we sought to determine whether depression and Neu
have any unique genetic correlations with other traits and disor-
ders after adjustment for the other variable.
Methods
Data sources
We used depression summary statistics from the Psychiatric
Genomics Consortium (PGC) (Wray et al., 2018), from the UK
Biobank (Howard et al., 2019) and from the 23andMe cohort
(Hyde et al., 2016). We also obtained PGC MD summary statistics
that included the 23andMe cohort, but excluded the UK Biobank
cohort (N = 431 394, 116 404 cases and 314 990 controls, preva-
lence = 0.27, 9 030 847 variants). We compared the depression
summary statistics with summary statistics for Neu (Luciano
et al., 2017) in UK Biobank (N = 329 821, 18 485 883 variants).
Pairwise GWAS of depression and neuroticism
To identify loci that contribute to variation in liability to depres-
sion, but not Neu, we used pairwise GWAS (Pickrell et al., 2016)
to jointly analyse summary statistics from depression and Neu.
Because this method requires that summary statistic sample over-
lap be minimised, we examined recent meta-analyses (Nagel et al.,
2018; Howard et al., 2019) and identified sources of summary
statistics that could yield the largest, independent sample sizes
for both sets of summary statistics. We used depression summary
statistics from the PGC MDD2 meta-analysis (Wray et al., 2018)
of PGC and 23andMe data that excluded summary statistics from
the UK Biobank sample (N cases = 116 404; N controls = 314 990);
for Neu we used summary statistics from the UK Biobank sample
(Luciano et al., 2017) (N = 329 821). We used the munge_sum-
stats.py tool (Bulik-Sullivan et al., 2015) to convert the summary
statistics to z-scores and to align and filter effect alleles to a com-
mon reference (HapMap 3 SNPs). Using these filtered summary
statistics, the gwas-pw program (Pickrell et al., 2016) models the
probability that each locus is associated with only one of the
two traits, the probability that the locus has a shared association
with both traits, and the probability that each of the genomic
regions contains separate loci that are associated with each trait.
We analysed the summary statistics by splitting them into gen-
omic segments (1702 in total) that were approximately independ-
ent based on linkage disequilibrium (Berisa and Pickrell, 2016).
To correct for potential cohort overlap, we first identified loci
that were not associated with both traits using the fgwas program
(Pickrell, 2014). We then retained segments that had a posterior
probability of association <0.2 with either trait. Using these non-
associated segments, we calculated the correlation of effect sizes
across the depression and Neu summary statistics, and then sup-
plied this correlation coefficient to gwas-pw. The gwas-pw pro-
gram performs a Bayesian test on each genomic region to
estimate the probability of unique or overlapping association sig-
nals from the two sets of GWAS summary statistics (Pickrell et al.,
2016).
Using the gwas-pw output, we categorised each segment as
being associated with depression only, Neu only, both traits or
neither trait. We defined depression-only segments as those that
had the highest posterior probability associated with only depres-
sion and that also had a genome-wide significant hit in the ori-
ginal GWAS but did not contain a genome-wide significant hit
for Neu (and vice versa for Neu-only segments). We defined seg-
ments that were associated with neither trait as those that had a
total posterior probability of association <0.2 and that did not
contain any genome-wide hits for either trait. To examine the
depression-only signal, we excluded segments associated with
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Neu or with both traits from the depression summary statistics,
clumped single-nucleotide polymorphisms (SNPs) that were in
linkage disequilibrium (LD) (r2 > 0.1) and within 3 Mb, then
used MAGMA (de Leeuw et al., 2015) to identify significantly
associated ( p < 2.77 × 10−6) genes and conducted GWAS catalogue
lookups using FUMA (Watanabe et al., 2017). We then conducted
the same set of analyses on the Neu-only segments from the Neu
summary statistics and the segments associated with both depres-
sion and Neu from the depression summary statistics.
Genetic correlations with depression adjusted for neuroticism
We used cross-trait genetic correlations to identify traits that were
related to MD after removing their shared genetic effects with
Neu. To start, we first obtained estimates of genetic correlations
from GWAS summary statistics that were downloaded from the
LD Hub (Zheng et al., 2017). The LD Hub results contained
information on genetic correlations with MDD from the PGC
(Major Depressive Disorder Working Group of the Psychiatric
GWAS Consortium, 2013) and Neu from the Genetics of
Personality Consortium (GPC) (de Moor et al., 2012). We selected
18 traits of interest that were nominally genetically correlated ( p <
0.01) with either MDD or Neu. These included psychiatric disor-
ders, personality traits, cardiovascular and inflammatory diseases,
anthropometric and life-history traits, education and lifestyle fac-
tors. We supplemented this list of traits with BMI since obesity
has been identified as a potential stratifying factor for depression
(Milaneschi et al., 2017) and retained the summary statistics for
GPC Neu as a check on the method. We also substituted summary
statistics from larger and more recent GWAS than those listed in
the LD Hub download, where available (online Supplementary
Table S1). For each trait of interest, we calculated its genetic correl-
ation using Linkage Disequilibrium Score (LDSC) regression
(Bulik-Sullivan et al., 2015) with the recent GWAS summary statis-
tics for MD and Neu. For depression we used a meta-analysis of
PGC, 23andMe and UK Biobank (Howard et al., 2019) and for
Neu we used data from UK Biobank (Luciano et al., 2017).
Our goal was to determine whether depression’s genetic correl-
ation with each trait of interest is (1) explained by the genetic
architecture shared between depression and Neu (‘neurotic
depression’) or (2) specific to depression and independent of
Neu (‘non-neurotic depression’) (and vice versa for ‘depressive
neuroticism’ and ‘non-depressive neuroticism’). We estimated
the genetic covariance among MD, Neu and each trait using
GenomicSEM (Grotzinger et al., 2019) and fitted a multiple
regression model:
Yg = b1MDg + b2Neug + uY
where Yg, MDg and Neug are the LDSC genetic values for trait Y,
major depression and Neu, respectively; b1 and b2 are regression
coefficients and uY is an error term. We used standardised esti-
mates of the regression coefficients to obtain the partial correla-
tions of MD after removing shared overlap with Neu, and vice
versa. We first identified traits that were genetically correlated
with MD but not with Neu. We then identified traits that were
genetically correlated with both depression and Neu but that
had a substantial partial genetic correlation with depression
after adjusting for Neu (MD·adjNeu) but not with Neu after
adjusting for depression (Neu·adjMD). Finally, we identified traits
with the opposite patterns of having genetic correlations that were
specific to Neu or to Neu after adjusting for depression. We tested
whether unadjusted and adjusted correlations were different from
zero and whether adjusted correlations were smaller than their
unadjusted counterparts and corrected for multiple testing using
False Discovery Rate (Benjamini and Yekutieli, 2001).
Results
Pairwise GWAS of depression and neuroticism
We used pairwise GWAS (Pickrell et al., 2016) between depres-
sion and Neu to partition genomic segments with association sig-
nals for MD only, for Neu only, for both traits or that contained
different associations for each trait. These associations were
assessed by posterior probabilities, where higher values mean
more probable. The correlation in beta coefficients from the sum-
mary statistics in genomic segments that were not associated with
either MD or Neu was r = 0.005, suggesting there was no
undetected sample overlap between the two studies. We identified
nine genomic segments containing loci that influence depression
but do not associate with Neu (i.e. association with depression-
only had the highest posterior probability) (Fig. 1, Table 1).
This represented 24% of the total 37 genomic segments that con-
tained loci previously associated with depression. The analysis
indicated that there were three genomic segments that contained
separate associations for depression and Neu (online
Supplementary Table S2 and Figs S1–S3). There were 25 GWAS
hits for depression that were also associated with Neu; in addition,
there were 45 more regions that, while below the threshold of
genome-wide significance for depression, the pairwise analysis
indicated were associated with both depression and Neu.
Finally, there were also 40 genomic segments that were signifi-
cantly associated only with Neu (online Supplementary Table S2).
We used MAGMA (de Leeuw et al., 2015) to identify genes
associated ( p < 2.77 × 10−6) with the partitioned genomic seg-
ments. There were 30 genes significantly associated with depres-
sion only (online Supplementary Table S3), 203 genes
associated with Neu only (online Supplementary Table S4) and
104 genes associated with both depression and Neu (online
Supplementary Table S5). We used FUMA (Watanabe et al.,
2017) to conduct GWAS catalogue lookups on these gene sets
(online Supplementary Table S6). MD was uniquely associated
with gene sets that are linked to N-glycan levels ( p = 1.1 × 10−8)
and to coronary heart disease ( p = 3.2 × 10−3). Neu-only gene
sets were related to traits such as intracranial volume,
Parkinson’s disease and high-density lipoprotein cholesterol.
The gene sets shared by depression and Neu were related to cross-
disorder psychiatric traits, coffee consumption and epilepsy,
among other traits (online Supplementary S6).
Partial genetic correlations with depression removing
neuroticism
The LD score genetic correlation between MD and Neu was 0.680
± 0.028 S.E. We fitted multiple regression models in GenomicSEM
to estimate the unadjusted genetic correlation of each trait of inter-
est with MD and with Neu and the partial genetic correlation with
depression where the shared overlap with Neu has been removed
(MD·adjNeu) and with Neu where overlap with depression has
been removed (Neu·adjMD) (Fig. 2, online Supplementary
Table S1). We grouped traits based on the pattern of their
unadjusted and adjusted genetic correlations with MD and Neu.
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Two traits were genetically correlated with both MD and Neu that
were slightly (depressive symptoms) or completely (sleep duration)
attenuated when adjusting for the other variable. Three traits (tri-
glycerides, BMI and conscientiousness) were genetically correlated
with MD but not Neu while another two traits (ulcerative colitis
and pubertal growth) were genetically correlated with Neu but
not with depression. There are two traits (apolipoprotein A-1
and bone density) that were correlated with neither MD nor Neu.
The multiple regression analyses identified traits correlated
with MD and Neu but that had specific genetic correlations
Fig. 1. Manhattan plot of pairwise GWAS of depres-
sion and Neu with genomic segments partition by
association with depression-only (blue), Neu only
(orange), both traits (green), separate associations
(red) or neither trait (grey).
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with only one of these phenotypes after adjusting for shared over-
lap with the other, wherein the partial correlation was maintained
for the focal phenotype but went to zero or had the opposite sign
for the other phenotype. MD had specific genetic correlations
with attention deficit hyperactivity disorder (ADHD), schizophre-
nia, bipolar disorder, coronary artery disease and age of first birth.
There were three additional traits [cigarettes smoked per day,
waist–hip ratio and chronotype (‘morningness’)] that showed a
similar pattern of full and partial correlations with MD, but
where the effect sizes overlapped with those for Neu, and thus
their status of having a specific relationship was less well sup-
ported. Finally, there were three traits (Neu measured in the
GPC, anorexia and years of schooling) that showed specific rela-
tionships with Neu after removing shared overlap with MD.
Discussion
We conducted complementary analyses to separate the specific
genetic features of MD from those that overlap with Neu and
vice versa. The pairwise GWAS analysis using depression results
from the PGC and 23andMe and Neu results from UK Biobank
revealed nine genomic regions that were significantly associated
with depression but not with Neu. Several of the associated
regions contained genes of known function: rs10913112 is down-
stream of RFWD2 (ring finger and WD repeat domain 2), a gene
that can promote tumour growth (Dornan et al., 2004); rs4660091
is near the fumarate hydratase gene (FH) which is involved in the
Krebs cycle; rs4143229 is in an intron of the ecto-NOX
disulphide-thiol exchanger 1 gene (ENOX1) which is expressed
in the nervous systems and has been implicated in autoimmune
disorders (Landouré et al., 2012) and rs1343605 is near
OLFM4, a gene that has been linked to depression (Wray et al.,
2018), inflammation and cancer (Liu and Rodgers, 2016).
There were 40 independent regions that were associated with
Neu but not depression. These included the two large inversion
polymorphisms, located on chromosomes 8 and 17, that have pre-
viously been associated with Neu (Okbay et al., 2016; Luciano
et al., 2017). These polymorphisms are thought to influence the
regulation of the genes in these regions, some of which are highly
expressed in the nervous (MAPT, MSRA, MTMR9) and immune
(BLK, MFHAS1) systems (Okbay et al., 2016). The remaining
regions of interest were associated with both depression and
Neu. These included the MHC region; DRD2, the dopamine D2
receptor involved in mood and emotion; MEF2C, a gene that reg-
ulates synaptic function; TCF4, a regulator of prefrontal neuronal
excitability and RBFOX1, a gene splicing regulator that has also
been implicated in other psychiatric disorders (Okbay et al.,
2016; Wray et al., 2018; Howard et al., 2019). There were 10
regions that did not contain genome-wide significant associations
in either depression or Neu summary statistics but that, when
analysed jointly in the pairwise analysis, appeared to be associated
with both traits. The novel loci included SNPs in or near the
DENND1B (DENN domain containing 1B) gene, which has
been implicated in childhood asthma (Sleiman et al., 2010);
RNF103 (ring finger protein 103), a suspected antidepressant tar-
get (Yamada et al., 2000) and genes related to axon guidance
(DCC netrin 1 receptor) (Kolodziej et al., 1996). There was also
a non-novel locus in the PCLO (piccolo presynaptic cytomatrix
protein) gene involved in synaptic vesicle trafficking that, while
not genome-wide significant in the PGC and 23andMe
meta-analysis (Wray et al., 2018) did reach genome-wide signifi-
cance separately for MDD in single cohort (Mbarek et al., 2017)
that is included in the PGC meta-analyses.
The pairwise GWAS also suggested three regions that con-
tained separate association signals for depression and Neu. For
example, a region (71.6–74.3 Mb on chromosome 1, online
Supplementary Fig. S1) contained two association signals for
depression. The first signal (rs1460942) was shared with Neu
and was close to the neuronal growth regulator 1 (NEGR1)
gene. A second association signal (rs12129573) was in the intron
of an uncharacterised non-protein coding RNA (LOC105378800).
In a further region, a signal was found (97.8–100.6 Mb on
chromosome 6) that showed a clear separation between the asso-
ciation signals for each trait (online Supplementary Fig. S3). The
SNP associated with depression (rs12202410) was near the F-box
and leucine-rich repeat protein 4 (FBXL4) gene which is related to
energy homoeostasis (Gai et al., 2013).
Using a GWAS catalogue lookup with FUMA (Watanabe et al.,
2017) on the pairwise GWAS results, we found that genes asso-
ciated with depression, but not with Neu, were also associated
Table 1. Genomic regions that are likely associated with depression but not with Neu that also contain a genome-wide significant SNP for depression
Chr Region (Mb)
Prob
(Dep
only) Prob(N only)
Prob
(both)
Prob
(separate) Top SNP BP A1/2
Dep. GWAS
p-value
1 175.090–177.433 0.533 0.001 0.287 0.094 rs10913112 175 913 828 T/C 3.02 × 10−8
1 241.583–242.071 0.657 3 × 10−4 0.176 0.032 rs4660091 241 628 430 T/C 4.64 × 10−8
4 174.267–176.568 0.011 0.004 0.004 0.001 rs75990749 175 349 867 C/G 2.22 × 10−8
9 1.920–3.185 0.449 0.001 0.413 0.053 rs7036618 2 990 717 A/C 3.92 × 10−8
12 119.759–121.989 0.380 0.005 0.222 0.092 rs77741769 121 363 835 T/C 2.53 × 10−8
13 43.109–44.901 0.595 0.001 0.151 0.123 rs4143229 44 327 799 A/C 2.50 × 10−8
13 53.340–54.681 0.800 3 × 10−13 0.108 0.120 rs1343605 53 647 048 A/C 3.09 × 10−18
15 37.461–38.528 0.514 7 × 10−7 0.363 0.001 rs834629 37 678 862 T/C 2.97 × 10−11
18 36.366–37.683 0.337 0.004 0.285 0.046 chr18_36904688_I 36 904 688 D/I 3.80 × 10−8
For each segment, the posterior probability of association (higher value means more probable) with depression only [Prob(Dep only)] is compared with Neu only [Prob(N only)], with the
same association signal for both traits [Prob(both)] or with separate association signals effecting each trait [Prob(separate)]. For each region, the top SNP associated with MDD is listed along
with its base pair position (BP) and GWAS p-value.
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with glycosylation and coronary heart disease. This suggests that
there may be subtypes of depression involving inflammation and
cardiovascular disease that are separate from subtypes of depres-
sion associated with Neu. In contrast, genes that were associated
with both depression and Neu were also associated with psycho-
logical, behavioural and psychiatric traits such as schizophrenia,
autism spectrum disorder and intelligence, suggesting that they
may influence behaviour and cognitive function more generally.
Differential association of MD with other traits, once shared
overlap with Neu was accounted for, was also shown in our ana-
lysis of LD score genetic correlations. We found that, unlike Neu,
MD was genetically correlated with BMI, triglyceride levels and
coronary artery disease, suggesting the atypical depressive subtype
related to cardio-metabolic traits (Lasserre et al., 2016; Milaneschi
et al., 2017). Even after removing shared genetic overlap with Neu,
MD was still specifically related to ADHD, schizophrenia, bipolar
Fig. 2. Genetic correlations of traits with MD and with Neu. Full, unadjusted correlations (green circles) and partial genetic correlations after adjusting for the other
variable (purple triangles) with 95% confidence intervals. We grouped traits based on the patterning of full and partial genetic correlations: both = genetically
correlated with MD and Neu, with specific or entirely shared overlap; MD specific = genetically correlated with depression but not Neu; MD·adjNeu specific =
fully correlated with both MD and Neu, but partially correlated with only MD; Possible MD·adjNeu specific = fully or partially correlated with depression and not
Neu, but substantial overlap in effect sizes; Neu·adjMD specific: fully correlated with both MD and Neu, but partially correlated with only Neu; Neu specific = genetically
correlated with Neu but not depression; neither = not genetically correlated with either depression or Neu.
6 Mark J. Adams et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291719002629
Downloaded from https://www.cambridge.org/core. University of Glasgow Library, on 04 Oct 2019 at 09:20:45, subject to the Cambridge Core terms of use, available at
disorder, coronary artery disease and age of first birth; and also
possibly to smoking, waist–hip ratio and chronotype (‘morning-
ness’). The robust association with schizophrenia and bipolar dis-
order after adjusting for overlap with Neu may indicate genetic
subtype heterogeneity among depression cases or the over-
inclusiveness of minimal depression phenotyping (Cai et al.,
2019). In contrast, the genetic architecture of depression that is
shared with Neu explained all or most of the genetic correlation
of depression with anorexia and years of schooling, which arise
from the worry/vulnerability and anxiety/tension subfactors of
Neu (Hill et al., 2019).
One limitation of our study is that by using summary statistics
from GWAS, we were only able to assess the overlap in genetic
architecture between depression and Neu that arises from com-
mon variants. Even biobank-sized samples of millions of partici-
pants can be underpowered for detecting associations with rare
variants unless such variants have very large effect sizes
(Visscher et al., 2017). While common variants contribute a
large proportion to phenotype heritabilities (Shi et al., 2016),
and thus trait covariances, it is not known how the strength of
any correlation will differ between rare and common polymorph-
isms (Shi et al., 2016, 2017). Furthermore there is evidence that
rare variants are associated with both Neu and depression
(Zeng et al., 2016; Hill et al., 2018). Much will depend on the evo-
lutionary history of both phenotypes. If, for example, antagonistic
pleiotropy, where a variant has opposite effects on two pheno-
types, is maintaining common variants, then rare variants
might be more likely to affect both traits in the same direction
(Carter and Nguyen, 2011). A second limitation is that we used
summary statistics for MD that were meta-analysed from studies
with varying levels of phenotyping depth and thus may be picking
up on genetic overlap that is more broadly shared with other psy-
chiatric disorders rather than specific to clinically defined MDD
(Cai et al., 2019). Another limitation is that our source studies
used case/control definitions of depression and sum-score quan-
tities of Neu, while other analyses of individual depressive symp-
toms (Thorp et al., 2019) and factors of Neu (Hill et al., 2019)
shows that depression and Neu are composed of subfactors that
themselves have unique associations with other traits.
Neu is a major risk factor for depression (Bagby et al., 1995;
Kendler et al., 2004), the two traits are strongly genetically corre-
lated (Jardine et al., 1984; Fanous et al., 2002; Luciano et al.,
2017), and Mendelian randomisation analysis has pinpointed
high Neu as a cause of depression (Howard et al., 2019). Our
results confirm that the majority of specific genetic variants asso-
ciated with depression are shared with Neu. However, we also
identified several association signals and overlap with other traits
that were unique to depression. In particular, the pairwise GWAS
analysis both identified new associations with depression and
separated out associations that were specific to depression while
the partial genetic correlation analysis identified other phenotypes
that are related to depression even after removing shared genetic
overlap with Neu. This suggests that that depression and Neu are
not just noisy measures of the same underlying liability. If these
differences represent distinct genetic subtypes of depression,
then most cases of depression will stem from this Neu–depression
nexus, while a smaller proportion may have aetiologies that are
distinct from Neu. Some of these associations, such as between
depression, chronotype and metabolic phenotypes, are suggestive
of endogenous depression’s features but do not point to all the
characteristics of this previously described subtype. Confirming
known depression subtypes and identifying new subtypes will
be useful for phenotypic and clinical stratification. The unique
associations of triglyceride levels and BMI with depression, but
not at all with Neu, confirms that depression with comorbid obes-
ity and other metabolic factors should be studied as a subtype
when exploring aetiology and testing treatment efficacy. The par-
tial genetic correlations that ADHD, schizophrenia and bipolar
disorder have with depression after adjusting for Neu imply that
polygenic risk scores for these other disorders may be useful to
screen or stratify participants even if they do not manifest these
other disorders.
Neither depression (Kendler et al., 2013; Thorp et al., 2019) nor
Neu (Hill et al., 2019) is completely genetically homogeneous.
Because the common variant genetic overlap is high between differ-
ent forms of assessing depression (clinically ascertained, brief ques-
tionnaire, hospital records) (Howard et al., 2018; Wray et al., 2018),
our results suggest that much of the shared genetic variance, where
depression and non-depression are on a continuum, is wrapped-up
in the Neu–depression nexus, and that going forward additional
studies based on a more refined, symptom-level analysis may be
more revealing for non-Neu-related forms of depression.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291719002629.
Data. The full MDD summary statistics from Hyde et al. are made available
through 23andMe to qualified researchers under an agreement with 23andMe
that protects the privacy of the 23andMe participants. Visit https://research.
23andme.com/collaborate for more information and to apply to access the
data. Summary statistics from the Psychiatric Genomics Consortium (Wray
et al., 2018; Howard et al., 2019) are available for download from http://
www.med.unc.edu/pgc/. Summary statistics for Neu in UK Biobank are avail-
able from the Centre for Cognitive Aging and Cognitive Epidemiology http://
www.ccace.ed.ac.uk/node/335.
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